Bellevue Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-97
| Closed | -$50.5K | – | 502 |
|
|
2024
Q4 | $50.5K | Hold |
97
| – | – | 0.03% | 155 |
|
|
2024
Q3 | $60K | Hold |
97
| – | – | 0.03% | 143 |
|
|
2024
Q2 | $53.6K | Hold |
97
| – | – | 0.03% | 143 |
|
|
2024
Q1 | $56.4K | Hold |
97
| – | – | 0.03% | 139 |
|
|
2023
Q4 | $51.5K | Hold |
97
| – | – | 0.05% | 148 |
|
|
2023
Q3 | $49.1K | Hold |
97
| – | – | 0.03% | 141 |
|
|
2023
Q2 | $50.6K | Hold |
97
| – | – | 0.03% | 148 |
|
|
2023
Q1 | $55.9K | Hold |
97
| – | – | 0.04% | 135 |
|
|
2022
Q4 | $53K | Hold |
97
| – | – | 0.04% | 144 |
|
|
2022
Q3 | $50K | Hold |
97
| – | – | 0.04% | 149 |
|
|
2022
Q2 | $53K | Hold |
97
| – | – | 0.04% | 150 |
|
|
2022
Q1 | $58K | Hold |
97
| – | – | 0.04% | 156 |
|
|
2021
Q4 | $65K | Hold |
97
| – | – | 0.04% | 151 |
|
|
2021
Q3 | $56K | Hold |
97
| – | – | 0.03% | 170 |
|
|
2021
Q2 | $49K | Hold |
97
| – | – | 0.03% | 177 |
|
|
2021
Q1 | $44K | Hold |
97
| – | – | 0.03% | 188 |
|
|
2020
Q4 | $50K | Hold |
97
| – | – | 0.03% | 172 |
|
|
2020
Q3 | $43K | Hold |
97
| – | – | 0.03% | 173 |
|
|
2020
Q2 | $35K | Hold |
97
| – | – | 0.04% | 200 |
|
|
2020
Q1 | $33K | Hold |
97
| – | – | 0.03% | 210 |
|
|
2019
Q4 | $32K | Buy |
+97
| New | +$32K | 0.02% | 208 |
|